Literature DB >> 34406206

Agreement and validity of asbestos-related cancers in the hospital information system of the Brazilian Unified Health System.

Diego Rodrigues Mendonça E Silva1,2, Carolina Terra de Moraes Luizaga3, Tatiana Natasha Toporcov4, Eduardo Algranti5.   

Abstract

OBJECTIVE: To estimate the degree of agreement and validity of diagnoses of asbestos-related malignant neoplasms registered in the Hospital Information System of the Brazilian Unified Health System (SIH/SUS), in comparison to the Hospital Cancer Registries of the State of São Paulo (HCR/SP).
METHODS: Deaths with records of malignant neoplasms associated with asbestos were identified and extracted from SIH/SUS between 2007 and 2014. Deaths in cases registered in the HCR/SP were extracted for the same period. The databases were linked using software Link Plus. A single ICD-10-coded diagnosis selected from each system was analyzed. The proportion of agreement, and the sensitivity, specificity and predictive values were estimated.
RESULTS: 19,458 pairs were found with records in both bases. The proportion of agreement was high, ranging from 92.4% for the unknown primary site, to 99.7% for cancer of the pleura. The Kappa Index ranged from 0.05 (95%CI 0.04 - 0.07) for cancer of the pleura to 0.85 (95%CI 0.84 - 0.87) for lung cancer. Sensitivity varied from 0.08 (95%CI 0.01 - 0.25) for cancer of the pleura, to 0.90 (95%CI 0.90 - 0.91) for lung cancer.
CONCLUSION: Diagnosis of asbestos-related malignancies reached higher levels of agreement and validity when common. Rare diagnoses showed low accuracy in SIH/SUS.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34406206     DOI: 10.1590/1980-549720210044

Source DB:  PubMed          Journal:  Rev Bras Epidemiol        ISSN: 1415-790X


  1 in total

1.  Analysis of Mortality from Asbestos-Related Diseases in Brazil Using Multiple Health Information Systems, 1996-2017.

Authors:  Eduardo Algranti; Vilma S Santana; Felipe Campos; Leonardo Salvi; Cézar A Saito; Franciana Cavalcante; Heleno R Correa-Filho
Journal:  Saf Health Work       Date:  2022-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.